HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">HOMA-IR quartiles</td><td align="center">1°</td><td align="center">2°</td><td align="center">3°</td><td align="center">4°</td></tr><tr class="thead"><td align="center">0.3–1.0</td><td align="center">1.1–1.8</td><td align="center">1.9–3.2</td><td align="center">3.3–10.5</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td align="left">BMI</td><td align="center">22.6</td><td align="center">23.5</td><td align="center">25.0</td><td align="center">25.1</td></tr><tr><td align="left">Leptin</td><td align="center">7.0</td><td align="center">10.5</td><td align="center">13.9</td><td align="center">20.7</td></tr><tr><td align="left">Adiponectin</td><td align="center">14.9</td><td align="center">14.4</td><td align="center">16.4</td><td align="center">16.0</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Mean baseline BMI, adiponectin, and leptin levels based on  quartiles distribution of HOMA-IR.

Gastroenterology Research and Practice

tab2

Table 2

Table 2: HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients 

Table 2 | HOMA, BMI, and Serum Leptin Levels Variations during Antiviral Treatment Suggest Virus-Related Insulin Resistance in Noncirrhotic, Nonobese, and Nondiabetic Chronic Hepatitis C Genotype 1 Patients 